Shailender Bhatia, MD
Dr. Bhatia is a medical oncologist who cares for patients with skin cancers and kidney cancer.Title
- Assistant Professor, Medical Oncology Division, University of Washington School of Medicine
Clinical Expertise
Skin cancers (melanoma, merkel cell cancer); kidney cancers
Education And Training
- All India Institute of Medical Sciences, New Delhi, India
- Residency: University of Connecticut Health Center
- Post-Doctoral Fellow: University of Washington
More Information
To read more about Dr. Bhatia, click here.
Visit PubMed for a full listing of Dr. Bhatia's journal articles.
Clinical Trials
Dr. Bhatia is the SCCA lead investigator for the following clinical trials:
- BNC105P w/ Everolimus for Metastatic Clear Cell Renal Cell Carcinoma (7712)
- Interleukin-12 by Electroporation for Merkel Cell Carcinoma
- IL-21/Ipilimumab Combination for Melanoma
- Biomarker Study of Anti-PD-1 in Advanced Melanoma
